Toggle navigation
Home
Search
Services
Blog
Contact
About
Phosphatidylinositol Phosphate Kinase and Transformation
Serunian, Leslie A.
Tufts University, Boston, MA, United States
Search 3 grants from Leslie Serunian
Search grants from Tufts University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms and Relevance of ENaC Regulation by AMP-Activated Kinase
Sodium Channel Isoform Expression in the Retina
Pathobiology of Human Leprosy
Costs and Outcomes of Two Protocols for Dental Sealants
Physiological roles of nuclear PLTP
Recently added grants:
Urban-Rural Disparities in Healthcare Quality for Children with Complex or Disabling Health Conditions
Bio-Behavioral Core
Implementation Science and Health Outcomes Core
Quantifying the attentional template
Center for HIV Identification, Prevention and Treatment Services (CHIPTS)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA008529-03
Application #
3033730
Study Section
(BI)
Project Start
1989-08-01
Project End
Budget Start
1989-08-01
Budget End
1989-11-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Institution
Name
Tufts University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Related projects
NIH 1989
F32 CA
Phosphatidylinositol Phosphate Kinase and Transformation
Serunian, Leslie A. / Tufts University
NIH 1988
F32 CA
Phosphatidylinositol Phosphate Kinase & Transformation
Serunian, Leslie A. / Whitehead Institute for Biomedical Research
NIH 1988
F32 CA
Phosphatidylinositol Phosphate Kinase and Transformation
Serunian, Leslie A. / Tufts University
Publications
Abbosh, Phillip H; Montgomery, John S; Starkey, Jason A et al.
(2006)
Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Cancer Res 66:5582-91
Comments
Be the first to comment on Leslie Serunian's grant